Scan: Will Elon Musk visit Mars before Aug 1, 2099?

← Back to scans

Will Elon Musk visit Mars before Aug 1, 2099?

KXELONMARS-99 · World · 2026-05-06

Agent

Market Price

-2.0%

Edge

60%

Confidence

Volume: 83,973

Spread: 2.0c

Days to resolution: 26749

Markets in event: 1

Final Rationale

I accept Challenge 1 and 2 fully: the 20.7% headline was an aggregation error driven by an unjustified contrarian ensemble member; my own conditional chain (0.55 × 0.30 × 0.25 ≈ 4.1%, plus small life-extension and dependency boosts) yields ~5-7%. I partially accept Challenge 3 (mild positive correlation between capability and willingness) and Challenge 4 (sq1 at 55% is slightly high given the 2026 Moon pivot, unsolved orbital refueling, and adjacent markets pricing human Mars landing before 2050 at 19-27%). Challenge 5 is accepted — transit mortality for a 70+ year old shaves additional probability. The market at 9% is illiquid (98-cent spread) so it's a weak signal, but it converges with my corrected structured estimate; I settle at 7%, slightly below market because the conjunction of Musk personally flying (vs. enabling others) is the binding constraint that founder-behavior base rates suggest is rarer than markets price.

Price vs. prediction

How the market moved after the agent's call. Solid blue line is the actual market price; dashed line is the agent's static forecast at $t{=}0$.

$n = 58$ follow-ups

Re-scan Context

This market has been scanned before. Previous predictions:

Date	Predicted	Market Price	Confidence
2026-04-29	7%	6%	30%
2026-04-03	11%	10%	25%

1. Planner Opus · Fermi decomposition + tool plan

Tools chosen: kalshi_data kalshi_orderbook article_search web_search wikipedia_lookup code_execution

Sub-questions (Fermi decomposition)

Will SpaceX or any organization successfully land humans on Mars before 2099? (w=0.35)
Will Elon Musk remain alive and physically capable of Mars travel at the time when crewed Mars missions first become available? (w=0.30)
Will Elon Musk personally choose to fly to Mars rather than only enabling others to do so? (w=0.20)
Will life-extension or medical technologies meaningfully extend Musk's viable lifespan beyond natural limits to allow a Mars visit? (w=0.15)

Planner reasoning

This 73-year resolution window question requires chaining multiple deep uncertainties. The key reference classes are: (1) no human has ever visited Mars; all attempts are robotic; (2) SpaceX Starship is the most credible crewed Mars vehicle but faces enormous engineering hurdles; (3) historical space program timelines consistently slip by decades. Musk is currently ~54 years old. For YES to occur, crewed Mars transport must exist AND Musk must be alive and healthy enough for the 6-9 month transit in extreme conditions. If first crewed Mars landing is 2035, Musk is 64 - plausible but demanding. If 2045, Musk is 74 - very demanding physiologically. If 2055+, natural survival and health become very unlikely without life-extension breakthroughs. The conditional structure is: P(YES) = P(crewed Mars possible) * P(Musk alive and healthy when available) * P(Musk personally goes). The 2099 deadline is generous in terms of technical feasibility but harsh for Musk personally given his 1971 birth year. Life-extension tech (senolytics, gene therapy, etc.) introduces a speculative upside tail. Musk has repeatedly stated his intention to go to Mars himself, providing evidence for sq3. The main bottleneck is the intersection of Mars mission readiness with Musk's health window, likely concentrated in a 2030-2055 window.

2. Research Parallel tool calls · legacy v2

Tool	Status	Time	Items
kalshi_data	OK	2.2s	-
kalshi_orderbook	OK	0.1s	-
article_search	OK	0.7s	-
web_search	OK	54.5s	-
wikipedia_lookup	OK	1.9s	-
code_execution	OK	0.0s	-

3. Evidence Synthesis Sonnet · 22 items · legacy v2

#	Strength	Credibility	Direction	Source	Claim	Priced In
1	STRONG	88	↓ DOWN	web_search	In February 2026, Elon Musk announced SpaceX is delaying Mars ambitions by 'about five to seven years' to focus on lunar missions, cancelling plans for an uncrewed 2026 Mars landing.	Yes
2	STRONG	87	↓ DOWN	article_search	Elon Musk confirmed in February 2026 that SpaceX is now prioritizing a 'self-growing city on the Moon' over Mars settlement, stating Moon is faster (travel every 10 days vs every 26 months for Mars).	Yes
3	STRONG	85	↓ DOWN	wikipedia_lookup	As of 2026, no humans have been beyond the Moon; only robotic landers, rovers and a helicopter have been on Mars, and Wikipedia notes SpaceX deprioritized Mars in 2026.	Yes
4	STRONG	82	↓ DOWN	web_search	A 2024 feasibility study published in Nature concluded that a crewed Mars mission using Starship is unworkable due to fundamental engineering constraints, including the unsolved orbital refueling challenge.	Yes
5	MODERATE	75	↓ DOWN	web_search	SpaceX has not yet demonstrated large-scale orbital propellant transfer between two spacecraft — a critical prerequisite for a Mars mission — and plans to attempt this in 2026.	Yes
6	STRONG	80	↓ DOWN	web_search	In May 2025, Musk estimated only a 50% chance SpaceX would be ready for the 2026/27 Mars launch window; the window was subsequently missed following the February 2026 pivot to Moon.	Yes
7	MODERATE	60	↓ DOWN	kalshi_data	The Kalshi market 'Will humans colonize Mars before 2050?' is priced at 19.2%, and 'Will a human land on Mars before California starts high-speed rail (before 2050)?' is at 27%, indicating moderate market skepticism about near-term crewed Mars missions.	Yes
8	MODERATE	58	↓ DOWN	kalshi_data	The market 'Will a humanoid robot walk on Mars before a human does (before 2035)?' is priced at 51.4%, suggesting markets believe robotic Mars missions are more likely than crewed missions in the near term.	Yes
9	STRONG	85	↓ DOWN	wikipedia_lookup	Historical pattern shows crewed Mars mission proposals since the 1950s have consistently been expected 10-30 years out from the time drafted, yet none have materialized; timelines consistently slip.	Yes
10	MODERATE	90	NEUTRAL	article_search	Artemis II (crewed lunar flyby) launched in April 2026, indicating crewed deep space travel is progressing — but only to the Moon level, not Mars.	Yes
11	STRONG	72	NEUTRAL	code_execution	Actuarial survival probability analysis shows Musk (born 1971, currently ~54.9 years old) has: ~95% survival to 2033 (age 62), ~87% to 2040 (age 69), ~68% to 2050 (age 79), ~19% to 2065 (age 94), and <1% to 2080 (age 109).	No
12	STRONG	70	↓ DOWN	code_execution	If first crewed Mars missions arrive in the optimistic 2033 window, Musk would be ~62 and survival probability is high (~95%), but if delayed to 2050+, his age (~79+) makes physical capability for a 6-9 month transit in extreme conditions very challenging.	No
13	MODERATE	72	NEUTRAL	web_search	The February 2026 pivot to Moon-first pushes SpaceX crewed Mars timeline to approximately 2031-2033 at earliest (5-7 year delay from 2026), putting Musk at age 60-62 for that scenario — within a plausible health window but demanding.	Yes
14	WEAK	55	↑ UP	article_search	No evidence found of serious health issues affecting Musk as of mid-2026; he is actively appearing in courts, making public statements, and running multiple companies.	Yes
15	STRONG	80	↓ DOWN	wikipedia_lookup	Mars transit requires 6-9 months one-way (or 3-4 months with full orbital refueling); this extended duration in microgravity and radiation exposure poses extreme physiological demands even for young, healthy individuals.	Yes
16	MODERATE	70	↑ UP	web_search	Musk has repeatedly stated his personal intention to go to Mars, most recently reaffirming this vision in 2024-2025 presentations, though the February 2026 Moon pivot does not explicitly address his personal travel plans.	Yes
17	MODERATE	68	NEUTRAL	article_search	Musk's February 2026 statement pivoting to Moon does not renounce personal Mars travel intentions — he frames it as a sequencing decision ('Moon is faster'), not an abandonment of the Mars vision.	Yes
18	WEAK	45	↓ DOWN	article_search	Musk's current focus in 2026 is heavily on legal battles (OpenAI trial, Twitter shareholder trial), political activity, and Tesla IPO, suggesting his priorities may be shifting away from personal space exploration.	Yes
19	WEAK	50	NEUTRAL	wikipedia_lookup	SpaceX Mars colonization program has always centered on Musk's stated desire to personally go; however, as founder/CEO, he may ultimately prioritize enabling others over taking personal risk in early missions.	Yes
20	WEAK	40	↓ DOWN	web_search	No specific evidence found of life-extension technologies (senolytics, gene therapy, etc.) advancing to the point where Musk's viable lifespan would be meaningfully extended beyond natural limits as of 2026.	Yes
21	MODERATE	68	↓ DOWN	code_execution	Without life-extension technologies, Musk's probability of being alive at 90 is only ~36% and at 95 is ~16%, making him very unlikely to be alive for Mars missions arriving after 2060.	No
22	MODERATE	62	↓ DOWN	kalshi_data	The primary Kalshi market (KXELONMARS-99) for Elon Musk visiting Mars before 2099 is priced at 9%, with low daily volume (413 contracts), a wide bid-ask spread of $0.98, and high orderbook depth of 99,082.	Yes

Information Gaps

No data on current state of SpaceX's orbital refueling tests in 2026 — this is a critical technical gating factor for any Mars mission
No information on China's crewed Mars mission timeline, which could compete with or complement SpaceX
No evidence on Musk's personal health status, fitness regime, or medical history relevant to space travel eligibility
No data on progress of life-extension technologies (senolytics, NAD+ therapies, gene therapies) that could extend Musk's viable health window
No information on what specific crewed Mars timeline SpaceX is now targeting after the 5-7 year delay announcement
No data on whether other space agencies (ESA, NASA, ISRO) have credible crewed Mars programs that could land before SpaceX
No information on Starship's current development status post-Moon pivot — whether the vehicle is still being optimized for Mars or deprioritized
No evidence on what Musk's own statements are about his personal desire to go to Mars following the 2026 Moon pivot
No actuarial data specific to ultra-high-net-worth individuals (who tend to have significantly better healthcare access and survival rates than population averages)

Key Uncertainties

The critical bottleneck: When will first crewed Mars mission actually occur? The 2026 Moon pivot adds 5-7 years minimum delay, pushing earliest crewed Mars to ~2031-2035 — but whether even that is achievable is deeply uncertain given unsolved orbital refueling challenge
Musk's health and physical capability at the time Mars missions first become available — if crewed Mars slips to 2040+, age ~69, the physiological demands of 6-9 month transit become increasingly severe
Whether life-extension or anti-aging technologies advance sufficiently in the 2026-2060 window to extend Musk's viable health beyond natural actuarial limits
Whether Musk personally chooses to board an early mission (high personal risk) vs. enabling others first — his stated intention conflicts with typical founder risk management behavior
Geopolitical continuity: Whether SpaceX maintains the technical leadership, funding, and regulatory environment needed to achieve crewed Mars over a 30-70 year horizon
Whether Musk maintains control of SpaceX long enough to have the authority to personally fly (corporate governance, regulatory, or personal circumstances could intervene)
The 73-year resolution window means many currently unforeseeable technologies and actors could emerge or disappear

Market Context

Price: 0.09 · 7d: +0.01 · 30d: -0.01
Volume: LOW-MODERATE — 413 contracts/day average for a 73-year resolution contract · Depth: HIGH — 99,082 depth, but spread is $0.98 (nearly the full range), indicating very illiquid pricing
Reliability: LOW — The extreme bid-ask spread ($0.01 bid / $0.01 no bid with $0.98 spread) indicates thin real price discovery despite high nominal depth. The 9% price may reflect genuine pessimism or simply lack of active market-making on a long-horizon speculative contract. Related markets (19-27% for human Mars colonization/landing before 2050) provide useful anchoring but have their own liquidity limitations.

4. Independent Forecaster Opus · No market price · legacy v2 Did NOT see market price

Independent estimate: 21% (42% confidence)

base rate

40% conf

evidence driven

35% conf

contrarian

50%

50% conf

Spread

45pp

High disagreement

sq1: Will any organization successfully land humans on Mars before 2099?

55%

Base rate: No humans have been beyond the Moon, and Mars mission proposals have slipped consistently for 70+ years. However, the 73-year window is very long. Given Apollo achieved Moon landing in ~10 years from serious commitment, and we have multiple actors (SpaceX, NASA, China) plus 73 years, a successful crewed Mars mission seems more likely than not. The 2026 Moon pivot pushes timelines but doesn't eliminate Mars. Key challenges (orbital refueling, radiation, life support) are engineering problems with decades to solve. I estimate 55% — meaningful chance of success across the long window, but real possibility of continued slippage, civilizational disruption, or shifting priorities.

sq2: Will Musk be alive and physically capable when crewed Mars becomes available?

30%

Conditional on sq1 happening, the timing matters. Actuarial data: Musk has ~95% survival to 2033 (age 62), 68% to 2050 (age 79), 19% to 2065 (age 94). Physical capability for 6-9 month microgravity transit is more demanding than mere survival — likely requires age <75 realistically. Given Mars missions most likely arrive in 2040-2060 window (post-2026 delays), Musk would be 69-89. Wealth-adjusted survival is somewhat better. Combined probability of being both alive AND fit enough at the right time: ~30%.

sq3: Will Musk personally choose to fly to Mars?

25%

Base rate for founder-class billionaires accepting multi-year mortality risk on flagship missions: essentially zero precedent. Branson/Bezos took suborbital hops, not 18-month interplanetary risk. Musk's stated intentions push up, but typical pattern is founders enable others first. Insurance, board pressure, family considerations, and the rational choice to send others first all push down. I estimate 25% — his stated commitment is genuine but rarely survives contact with actual mission planning.

sq4: Will life-extension technologies meaningfully extend Musk's viable Mars window?

10%

No current evidence of breakthrough life-extension technologies. Despite decades of research, no intervention has demonstrably extended healthy human lifespan beyond normal ranges. 73-year window allows for possible breakthroughs, but transformative anti-aging by 2060 (when needed) remains speculative. ~10%.

Show full reasoning trace

base rate: No human has visited Mars; no founder-billionaire has accepted multi-year mission risk. Base rate for the conjunction is very low, in the low single digits.

evidence updates: February 2026 Moon pivot pushes Mars timeline 5-7 years later, reducing Musk's health window. Unsolved orbital refueling is a hard technical gate. Musk is 54 and apparently healthy, preserving near-term optionality. Stated personal intention to go provides modest upward pressure on sq3.

combination method: Conditional chain across three near-independent gates (Mars happens, Musk capable, Musk personally goes), with small tail boost for life-extension and timing correlation.

final: Combined estimate ~5%. The conjunction is dominated by the requirement that Musk personally fly during a narrow window where he is both alive/fit and Mars travel exists — a narrow intersection given likely timeline slippage and founder risk-aversion patterns.

ensemble: {'ensemble_count': 3, 'perspectives': {'base_rate': {'p_yes': 0.05, 'confidence': 0.4}, 'evidence_driven': {'p_yes': 0.07, 'confidence': 0.35}, 'contrarian': {'p_yes': 0.5, 'confidence': 0.5}}, 'spread': 0.45, 'individual_p_yes': {'base_rate': 0.05, 'evidence_driven': 0.07, 'contrarian': 0.5}}

5. Devil's Advocate Sonnet · legacy v2 Market price revealed

Math Error Reasoning Flaw Overconfidence

Challenges

Math inconsistency: Your sub-questions multiply to 0.55 × 0.30 × 0.25 = 0.041 (4.1%), plus a small life-extension boost. Yet your 'Combined p_yes' is reported as 0.207 (20.7%). The reasoning trace itself says 'Combined estimate ~5%'. The 0.207 appears to come from averaging the ensemble (including a contrarian 0.50), not from the conditional chain. This is a significant aggregation error — the contrarian perspective at 0.50 with confidence 0.50 is dragging the ensemble mean far above what the structured decomposition supports.
The contrarian ensemble member at 0.50 lacks justification in the trace. Giving it equal weight to base-rate and evidence-driven perspectives (which both land at 5-7%) inflates the final number without a stated reason why the contrarian view deserves ~33% weight. A more defensible aggregation would weight by confidence or use the structured chain as the primary anchor.
sq2 (capability) and sq3 (chooses to fly) may not be near-independent as assumed. If Musk is alive and capable in a world where Mars travel is routine and safer (later in the window), his willingness goes up; conversely earlier risky missions correlate with lower willingness. This dependency could push the conjunction slightly higher than pure multiplication, but the effect is small — does not justify 20.7%.
sq1 at 55% may be slightly optimistic given the strong DOWN evidence (2024 Nature feasibility study calling Starship Mars 'extremely unlikely' before 2040, the 2026 Moon pivot, unsolved orbital refueling, and related markets pricing human Mars landing before 2050 at ~19-27%). A 73-year window is long, but 55% conflicts with adjacent market signals and recent strong negative evidence.
The forecast does not adequately address that even if all three gates pass, 'visit' requires Musk to actually arrive alive — Mars transit mortality risk for a 70+ year old is non-trivial and should shave another few percent.

Suggested adjustment: -12pp

The headline 0.207 contradicts the forecaster's own structured reasoning (which yields ~5%) and own trace conclusion ('Combined estimate ~5%'). The discrepancy comes from an unjustified ensemble that gives equal weight to a contrarian 0.50 with no supporting argument. Fixing this aggregation error alone moves the forecast to roughly 0.06-0.10, which happens to align with the market but the adjustment is driven by an internal math/aggregation flaw, not market conformity.

Market comparison: Forecaster: 20.7%, Market: 9%. The divergence is largely an artifact of the forecaster's ensemble aggregation overriding their own conditional-chain analysis (which produced ~5%). The market at 9% is illiquid (98-cent spread) so it's not a strong signal, but the related-market anchors (19-27% for any human Mars landing before 2050) and the structured decomposition both suggest the true forecast should be in the 5-10% range, not 20%.

6. Aggregator Opus · final calibrated forecast

7% (60% confidence)